Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
CNSide expands coverage to ~1.2 million people in Ohio and Kentucky, bringing total contracted coverage to approximately 127 million people.
CNSide expands coverage to ~1.2 million people in Ohio and Kentucky, bringing total contracted coverage to approximately 127 million people.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.